This non-invasive therapy greatly reduces inflammation and improves circulation, making it an effective and low-cost relief for arthritis, cardiovascular and peripheral vascular diseases, MS, lupus, fibromyalgia, Lyme disease, and other disorders and ailments. Medsonix has undergone several years of independent research, including two controlled university research studies focusing on therapeutic effects on PVD and arthritis, and has been granted three U.S. patents. The company's integrated medical device is designed to increase blood flow and mobility by using low frequency sound pressure to decrease inflammation, enabling healthcare providers to provide the treatment of diseases and disorders like arthritis, diabetes, cardiovascular disease, and fibromyalgia. Currently, Medsonix is available in several states and is marketed as "medically significant."